Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AcelRx Pharmaceuticals has appointed James Welch as the new chief financial officer (CFO) of the company.
Subscribe to our email newsletter
Most recently, Welch was the chief financial officer at Cerimon Pharmaceuticals, a Pharmaceutical company engaged in developing pain products.
Prior to joining, Cerimon, Welch was the chief financial officer and corporate secretary at Rigel Pharmaceuticals.
AcelRx president and CEO Richard King said that Jim brings over two decades’ experience in financial and operational management at life science and high technology firms.
AcelRx Pharmaceuticals is a pharmaceutical company engaged in the development and commercialisation of products for the treatment of painful conditions where currently available treatments are not optimal.